Aristotle University Of Thessaloniki (AUTH)
Διερεύνηση στόχων γονιδιακής θεραπείας στη διαβητική μακροαγγειοπάθεια: το σύστημα AGEs-RAGE και ο PPARγ στα μονοκύτταρα
Abstract
dc:description[…] Aim: In the study we examined the importance of AGEs-RAGE system, the nuclear receptor PPARγ and monocytes surface antigen CD36 in diabetic macroangiopathy and we explored the possibility of RAGE gene therapy. Therefore we investigated: a) SRAGE levels in diabetics with CAD and in non-diabetics without CAD, b) the relationship between serum fluorescent AGEs and SRAGE and atheromatic plaque in diabetics with CAD, c) the effect of siRNA induced RAGE inhibition in monocytes from diabetics and controls in regard to production of ROS and CD36 after AGEs administration and d) the prevalence of PPARγ Pro12Ala polymorphism in diabetics with CAD, without CAD and in controls. […]
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ξάνθης, Ανδρέας
- Xanthis, Andreas
Subjects
dc:subject × 12- Τελικά προϊόντα προχωρημένης γλυκοζυλίωσης
- Διαβητική μακροαγγειοπάθεια
- Γονιδιακή θεραπεία με SIRNA
- PPARγ πολυμορφισμός PVOITALA
- Advanced glycosylation end products
- Diabetic vascular disease
- Gene therapy with SIRNA
- PPARγ gene polymorphism Pro12ala
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24752